Yale Cancer Center Advanced Training Program for Physician-Scientists (YCC-ATPP)

耶鲁大学癌症中心医师科学家高级培训计划 (YCC-ATPP)

• 批准号: 10450030
• 负责人: Lieping Chen
• 金额: $ 30.67万
• 依托单位: YALE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-08-01 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10450030
• 关键词: Physicians; Scientist; Training Programs; Yale Cancer Center

PROJECT SUMMARY/ABSTRACT This resubmission titled “Yale Cancer Center Advanced Training Program for Physician-scientists (YCC-ATPP)” requests five years of support for an intensive hematology and medical oncology (Heme/MedOnc) fellowship research training program at the Yale School of Medicine (YSM)/Yale Cancer Center (YCC). Our record of training Heme/MedOnc fellows is strong. Our trainees have gone on to major positions of leadership and success in academic and clinical hematology and oncology settings. Since 1987, 151 fellows have completed the Heme/MedOnc Fellowship Program (originally as separate disciplines; now as a joint program since 2012), and 46 of the 72 graduates who completed the program within the last 10 years work in academic positions, many with independent funding. Bolstered by the recent investment in our cancer center by Yale University and Yale-New Haven Hospital, including increased institutional commitment and faculty recruitment in recent years (many with peer-reviewed funding), we believe the structure and support provided by this T32 will allow trainees to achieve even greater success and will further increase the numbers of accomplished independent physician-scientist leaders completing our program. This T32 will build on a foundation of excellence established during clinical training in our Heme/MedOnc Fellowship Program, from which fellows will be able to apply to this program. As such, the prospective trainees will have already received an MD or MD/PhD degree, completed internal medicine residency, and 2 years of clinical fellowship training in Heme/MedOnc. This T32 program will select the most highly qualified and diverse candidates from this group who wish to pursue a career in cancer research and numerous procedures have been put in place to ensure the recruitment, quality mentorship, and retention of under-represented minority fellows. This advanced training program will provide outstanding mentored basic, translational, clinical, and outcome-based cancer research experiences from senior and expert junior faculty in a highly collegial, collaborative, and integrative institutional environment. This program is designed to provide essential financial support and ensure precious protected time is given to our fellows for research, allowing them to establish themselves early on as physician-scientists, and paving the way towards a successful academic career. Along these lines, the program includes career development planning and mentorship committees including scientists and physicians with knowledge and experience in the trainee’s research field to provide guidance throughout the length of the program. At the conclusion of their training, it is our goal that individuals supported by this T32 will have developed the skills necessary to function independently, including the ability to design, initiate, and complete research projects, and to effectively write grants and manuscripts. The T32 will firmly position Heme/MedOnc fellows as independent clinical, translational, or basic cancer researcher leaders of tomorrow.

项目摘要/摘要 这个标题为“耶鲁癌症中心高级培训计划的重新提交医师科学家的高级培训计划 （YCC-ATPP）”请求对强化血液学和医学肿瘤学的五年支持 （血红素/MEDONC）耶鲁大学医学院（YSM）/耶鲁癌症奖学金研究培训计划 中心（YCC）。我们训练血红素/Medonc研究员的记录很强。我们的培训已经开始 在学术和临床血液学和肿瘤学环境中领导和成功的立场。自1987年以来 151名研究员已经完成了血红素/Medonc奖学金计划（最初是单独的学科；现在 自2012年以来的联合计划），在过去10年中完成该计划的72名毕业生中有46个 在学术职位上工作，许多拥有独立资金。最近对我们癌症的投资得到了支持 耶鲁大学和耶鲁大学新医院的中心，包括增加机构承诺和 近年来，教师招聘（许多接受了同行评审的资金），我们相信结构和支持 由该T32提供的将使受训者获得更大的成功，并将进一步增加数字 完成了我们计划的成就独立的身体科学家领导者。 该T32将建立在我们的临床培训期间建立的卓越基础的基础 血红素/MEDONC奖学金计划，研究员可以从中申请此计划。因此， 准学员将已经获得医学博士学位或医学博士学位，完成了内科医学 在血红素/MEDONC中的长期培训和2年的临床奖学金培训。这个T32程序将选择最多 希望从事癌症研究事业的该小组的高素质和多样化的候选人 已经制定了许多程序，以确保招募，质量心态和保留 代表性不足的少数民族。该高级培训计划将提供出色的心理基础， 高级和专家初级教师的转化，临床和基于结果的癌症研究经验 高度合作，协作和综合的机构环境。该程序旨在提供 基本的财政支持，并确保给我们的研究员提供宝贵的保护时间，以便 他们尽早成为身体科学家，并为成功的道路铺平道路 学术生涯。沿着这些计划，该计划包括职业发展计划和心态 委员会在内 在整个计划的长度上提供指导。在他们的培训结束时，我们的目标是 由该T32支持的个人将发展独立运作所需的技能，包括 设计，启动和完成研究项目以及有效撰写赠款和手稿的能力。 T32首先将血红素/Medonc研究员定位为独立的临床，翻译或基本癌症 明天的研究人员领袖。